Neuroone Medical Technologies (NMTC) Gross Margin (2011 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Gross Margin came in at 53.18% in Q1 2026, down 243.0% YoY from 37.19% in Q1 2025, and down 1.88% on a QoQ basis from 54.2% in Q4 2025.
Neuroone Medical Technologies (NMTC) Gross Margin (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 11 years of Gross Margin data on file, last reported at 53.18% in Q1 2026.
- Quarterly Gross Margin fell 243.0% year-over-year to 53.18% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 54.41% (up 22.0% YoY) and the FY2025 annual result came in at 56.51%, up 2525.0% from the prior year.
- Gross Margin declined to 53.18% in Q1 2026, from 54.2% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 58.85% in Q4 2024 to a low of 99.01% in Q1 2022.
- A 5-year average of 23.12% and a median of 34.13% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin soared 10577 bps — and 2025, when it slumped 465 bps.
- Tracing NMTC's Gross Margin over 5 years: stood at 10.74% in 2022, then jumped by 354 bps to 27.24% in 2023, then jumped by 116 bps to 58.85% in 2024, then dropped by 8 bps to 54.2% in 2025, then retreated by 2 bps to 53.18% in 2026.
- The last three Gross Margin figures came in at 53.18% (Q1 2026), 54.2% (Q4 2025), and 55.77% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 45.84% |
| 10 | Neuroone Medical Technologies | 19.40 Mn | 17.35 Mn | 1.18 Mn | 59.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.94% |
| Mar 31, 2026 | 53.18% |
| Dec 31, 2025 | 54.20% |
| Sep 30, 2025 | 55.77% |
| Jun 30, 2025 | 53.94% |
| Mar 31, 2025 | 55.61% |
| Dec 31, 2024 | 58.85% |
| Sep 30, 2024 | 51.81% |
| Jun 30, 2024 | 34.13% |
| Mar 31, 2024 | 28.35% |
| Dec 31, 2023 | 27.24% |
| Sep 30, 2023 | 26.11% |
| Jun 30, 2023 | 38.68% |
| Mar 31, 2023 | 6.76% |
| Dec 31, 2022 | -10.74% |
| Sep 30, 2022 | -21.90% |
| Jun 30, 2022 | -20.01% |
| Mar 31, 2022 | -99.01% |
| Dec 31, 2021 | -38.81% |
| Sep 30, 2021 | -35.44% |